aTyr Pharma reported $110.08M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Alterity Therapeutics Limited AUD 596.04K 584.66K Dec/2025
Ardelyx USD 94.47M 30.74M Mar/2026
aTyr Pharma USD 110.08M 109.89M Dec/2025
Biogen USD 2.25B 30M Mar/2026
Bristol-Myers Squibb USD 11.49B 1.01B Mar/2026
Cipla INR 65.41B 9.77B Mar/2026
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 6.35M 60.98M Mar/2026
CSL USD 8.33B 4.79B Dec/2025
Curis USD 1.14M 1.41M Dec/2025
GlaxoSmithKline GBP 7.63B 991M Mar/2026
Grifols EUR 2B 306.7M Mar/2026
Lakefront Biotherapeutics EUR 6.5M 894.32M Mar/2026
Novartis USD 13.11B 226M Mar/2026
Roche Holding CHF 15.65B 274.5M Dec/2025
United Therapeutics USD 781.5M 8.7M Mar/2026
Xoma USD 25K 5M Sep/2024